Clinical Trial Update: Intravenous Immunoglobulin and Prednisolone for RPL After ART. [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating intravenous immunoglobulin plus prednisolone for recurrent pregnancy loss after assisted reproductive technology has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility
• Pregnancy Loss
• Spontaneous Abortion

Drugs mentioned

• Intravenous Immunoglobulin (IVIG)
• Prednisolone (Prednisolone)

Snippet

Sponsor: Aalborg University Hospital | Conditions: Habitual Abortion, Recurrent Pregnancy Loss | Phase 2 | Status: COMPLETED